NORMAN BARKER, JR.

Corporate Board Profile

Tech Score: 0/100

TCW STRATEGIC INCOME FUND INC

Filing Date	Source Excerpt
2002-06-04	Norman Barker, Jr.(79) Term: Until Private Investor. 29 ICN Pharmaceuticals, 9601 Wilshire Blvd. 2003. Served Inc., TCW Galileo Beverly Hills, CA since 1987. Funds, Inc. The Board of Directors has not designated a nominating committee of the Board. Each Independent Director is a member of the Audit Committee. The Fund pays each Independent Director an annual fee of $7,500 plus a per meeting fee of $750 for meetings of the Board of Directors or Committees of the Board of Directors attended by the Director. The following table illustrates the compensation paid to the Fund's Independent Directors by the Fund for the fiscal year ended December 31, 2001. Norman Barker, Jr...... 12,250

Filing Date

Source Excerpt

2002-06-04

Norman Barker, Jr.(79) Term: Until Private Investor. 29 ICN Pharmaceuticals, 9601 Wilshire Blvd. 2003. Served Inc., TCW Galileo Beverly Hills, CA since 1987. Funds, Inc. The Board of Directors has not designated a nominating committee of the Board. Each Independent Director is a member of the Audit Committee. The Fund pays each Independent Director an annual fee of $7,500 plus a per meeting fee of $750 for meetings of the Board of Directors or Committees of the Board of Directors attended by the Director. The following table illustrates the compensation paid to the Fund's Independent Directors by the Fund for the fiscal year ended December 31, 2001. Norman Barker, Jr...... 12,250

Data sourced from SEC filings. Last updated: 2026-02-03